Jeanann Vawter, NP
Nurse Practitioner · Gastonia, NCNPI 1043253776
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $62,900 of the $97,024 with a category attached, or 64.8%. Johnson & Johnson accounts for 82.0% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2022 at $35,573 and has fallen 66.5% since, to $11,907 in 2025. Among nurse practitioner clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 345 payments — averaging $281.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$80K
- Coloplast$5K
- Axonics, Inc.$3K
- Teleflex LLC$2K
- Boston Scientific$2K
- Janssen Scientific Affairs, LLC$2K
- plus $3K from 22 others
What the payments were for
- Consulting fees$2,0632%
- Speaking & faculty fees$62,90065%
- Travel & lodging$14,25315%
- Food & beverage$17,57618%
- Education$2330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 131 | $79,547 |
| Coloplast | 60 | $5,235 |
| Axonics, Inc. | 35 | $3,347 |
| Teleflex LLC | 27 | $2,266 |
| Boston Scientific | 16 | $1,661 |
| Janssen Scientific Affairs, LLC | 8 | $1,523 |
| Myriad Genetic Laboratories, Inc. | 10 | $712 |
| Agiliti Surgical, Inc. | 6 | $632 |
| Medtronic | 5 | $343 |
| Astellas Pharma US Inc | 10 | $261 |
| Laborie Medical Technologies Corp. | 2 | $230 |
| Urogen Pharma, Inc. | 1 | $177 |
| Foundation Medicine, Inc. | 1 | $145 |
| AstraZeneca | 3 | $143 |
| Novo Nordisk | 2 | $130 |
| Tempus AI, Inc | 1 | $118 |
| Sumitomo Pharma America, Inc. | 3 | $89 |
| AbbVie | 2 | $68 |
| Endo Pharmaceuticals Inc. | 4 | $66 |
| Dendreon Pharmaceuticals LLC | 4 | $65 |
| Pfizer | 2 | $56 |
| Urovant Sciences Inc | 3 | $48 |
| Myovant Sciences Inc. | 2 | $42 |
| Amgen | 2 | $34 |
| Bayer | 2 | $27 |
| Blue Earth Diagnostics | 1 | $26 |
| Merck | 1 | $19 |
| Antares Pharma, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Erleada$70,616
- AKEEGA$11,345
- RYBREVANT$8,760
- CARVYKTI$8,760
- Axonics r-SNM System$1,390
- UroLift$1,360
- Axonics$1,117
- TITAN$968
- ALTIS$880
- Coloplast TFL Drive$844
- LithoVue$592
- Porges Coloplast$532
- UroLift System$394
- Saffron$382
- Isiris aStent Removal Device$330
- GreenLight XPS Laser$285
- Optilume BPH Drug Coated Balloon Catheter$230
- JELMYTO$177
- Barrigel$174
- GreenLight XPS$150
How this compares
$97,024 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 112 | $1,747,698 |
| NubeqaDarolutamide | 26 | $349,978 |
| MyrbetriqMirabegron | 146 | $114,417 |
| GemtesaVibegron | 25 | $27,443 |
| Methenamine Hippurate | 210 | $21,080 |
| Potassium Citrate ErPotassium Citrate | 70 | $8,617 |
| Mirabegron ErMirabegron | 22 | $8,563 |
| Solifenacin Succinate | 167 | $8,025 |
| PremarinEstrogens, Conjugated | 18 | $7,873 |
| Tamsulosin Hcl | 510 | $6,732 |
| Silodosin | 51 | $4,459 |
| Estradiol | 37 | $2,109 |
| Tolterodine Tartrate ErTolterodine Tartrate | 23 | $1,746 |
| Testosterone Cypionate | 37 | $1,622 |
| Finasteride | 83 | $1,451 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $79,547 | $1,747,698112 claims |
| BayerNubeqa | $27 | $349,97826 claims |
| Astellas Pharma US IncMyrbetriq | $261 | $114,417146 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $89 | $27,44325 claims |
| PfizerPremarin | $56 | $7,87318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Gastonia
- Chakun McDanielGastonia$11K
- Sandrivette JohnsonRaleigh$573K
- Ayeshia WrightMocksville$145K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
- Bridget ArchambaultDurham$57K
- Deborah MayerChapel Hill$55K
- Amber SeilerGreensboro$55K
- Stephanie PascaleRaleigh$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.